7 results
10-K
2023 FY
GUTS
Fractyl Health Inc.
1 Apr 24
Annual report
7:15am
The assumptions used to estimate the grant date fair value of the option awards granted to our named executive officers in November 2023, for such portion not qualifying as “incentive stock options,” were as follows:
Risk-free interest rate | 4.61 | % | ||
Expected term (in years) | 5.92 | |||
Expected volatility | 60 | % | ||
Expected dividend yield | 0 | % | ||
Grant date fair value | $ | 6.70 |
10-K
2023 FY
GUTS
Fractyl Health Inc.
1 Apr 24
Annual report
7:15am
The following table sets forth information concerning the total compensation of our named executive officers for the year ended December 31, 2023:
Name and Principal Position | Year | Salary ($) | Bonus ($)(1) | Stock Awards ($) | Option Awards ($)(2) | Non-Equity Incentive Plan Compensation ($)(3) | All Other Compensation ($)(4) | Total ($) | ||||||||||||||||||||||
Harith Rajagopalan, M.D., Ph.D. | 2023 | $ | 550,000 | $ | 2,430,014 | $ | 267,990 | $ | 313,500 | $ | 270 | $ | 3,561,774 | |||||||||||||||||
Chief Executive Officer | 2022 | $ | 550,000 | — | $ | 78,602 | $ | 221,100 | $ | 280 | $ | 849,982 | ||||||||||||||||||
Timothy Kieffer, Ph.D.(5) | 2023 | $ | 92,438 | $ | 25,000 | — | $ | 3,321,650 | $ | 23,200 | $ | 3,462,288 | ||||||||||||||||||
Chief Scientific Officer | ||||||||||||||||||||||||||||||
Jay D. Caplan | 2023 | $ | 400,000 | $ | 2,097,678 | $ | 220,507 | $ | 154,000 | $ | 1,188 | $ | 2,873,373 | |||||||||||||||||
President and Chief Product Officer |
10-K
2023 FY
GUTS
Fractyl Health Inc.
1 Apr 24
Annual report
7:15am
The following table summarizes the number of shares of common stock underlying outstanding equity incentive plan awards for each named executive officer as of December 31, 2023.
Option Awards | |||||||||||||||||||||||||||
Name | Vesting Start Date | Underlying Un-exercised Options (#) Exercisable | Underlying Un-exercised Options (#) Un-exercisable | Option Exercise Price ($) | Option Expiration Date | Number of Shares or Units of Stock that have not Vested (#) | Market Value of Shares of Units of Stock that have not Vested ($)(1) | ||||||||||||||||||||
Harith Rajagopalan, M.D., Ph.D.(2). | 8/19/2014 | 190,968 | 0 | 1.70 | 11/10/2024 | — | — | ||||||||||||||||||||
3/01/2015 | 123,484 | 0 | 1.70 | 2/09/2025 | — | — | |||||||||||||||||||||
12/17/2015 | 345,078 | — | $ | 2.67 | 12/16/2025 | — | — | ||||||||||||||||||||
6/27/2016 | 179,868 | 0 | 2.67 | 6/26/2026 | — | — | |||||||||||||||||||||
3/14/2018 | 422,473 | 0 | 3.35 | 3/13/2028 | — | — | |||||||||||||||||||||
3/26/2020 | 445,333 | 29,688 | 3.89 | 3/25/2030 | — | — | |||||||||||||||||||||
6/24/2021 | 164,335 | 98,602 | 6.98 | 6/23/2031 | — | — | |||||||||||||||||||||
9/07/2022 | 5,096 | 11,213 | 8.59 | 9/06/2032 | — | — | |||||||||||||||||||||
3/16/2023 | 6,116 | 26,502 | 8.18 | 3/15/2033 | — | — | |||||||||||||||||||||
11/10/2023 | 0 | 17,031 | (3) | 11.21 | 11/09/2033 | — | — | ||||||||||||||||||||
$ | 325,386 | ||||||||||||||||||||||||||
11/10/2023 | — | — | — | 11/09/2030 | 216,924 | (7) | 0 | ||||||||||||||||||||
Timothy Kieffer, Ph.D. | 10/14/2022 | 5,436 | (4) | 3,883 | 8.59 | 12/06/2032 | — | — | |||||||||||||||||||
9/12/2023 | 0 | 498,005 | (5) | 11.21 | 9/12/2033 | — | — | ||||||||||||||||||||
Jay D. Caplan(6) | 8/19/2014 | 95,484 | 0 | 0.82 | 11/10/2024 | — | — | ||||||||||||||||||||
3/01/2015 | 61,742 | 0 | 1.70 | 2/09/2025 | — | — | |||||||||||||||||||||
12/17/2015 | 145,875 | — | $ | 2.67 | 12/16/2025 | — | — | ||||||||||||||||||||
6/27/2016 | 23,298 | 0 | 2.67 | 6/26/2026 | — | — | |||||||||||||||||||||
3/14/2018 | 94,879 | 0 | 3.35 | 3/13/2028 | — | — | |||||||||||||||||||||
3/26/2020 | 12,022 | 802 | 3.89 | 3/25/2030 | — | — | |||||||||||||||||||||
6/24/2021 | 24,358 | 14,616 | 6.98 | 6/23/2031 | — | — | |||||||||||||||||||||
9/07/2022 | 3,639 | 8,010 | 8.59 | 9/06/2032 | — | — | |||||||||||||||||||||
3/16/2023 | 4,805 | 20,823 | 8.18 | 3/15/2033 | — | — | |||||||||||||||||||||
11/10/2023 | 0 | 14,701 | (3) | 11.21 | 11/09/2033 | — | — | ||||||||||||||||||||
11/10/2023 | — | — | — | 11/09/2030 | 187,257 | (7) | $ | 2,808,855 |
10-K
2023 FY
GUTS
Fractyl Health Inc.
1 Apr 24
Annual report
7:15am
Incorporated by Reference | ||||||
Exhibit Number | Exhibit Description | Form | File No. | Exhibit | Filing Date | Filed/ Furnished Herewith |
10.4† | Fractyl Health, Inc. Amended and Restated 2011 Stock Incentive Plan and forms of award agreements thereunder. | S-1 | 333-276046 | 10.4 | 12/14/2023 | |
10.5† | Employment Letter Agreement, dated January 26, 2024, by and between Fractyl Health, Inc. and Harith Rajagopalan, M.D., Ph.D. | S‑1/A | 333-276046 | 10.5 | 1/29/2024 | |
10.6† | Employment Letter Agreement, dated January 26, 2024, by and between Fractyl Health, Inc. and Lisa A. Davidson. | S‑1/A | 333-276046 | 10.6 | 1/29/2024 | |
10.7† | Employment Letter Agreement, dated January 26, 2024, by and between Fractyl Health, Inc. and Jay D. Caplan. | S‑1/A | 333-276046 | 10.7 | 1/29/2024 | |
10.8† | Employment Letter Agreement, dated January 26, 2024, by and between Fractyl Health, Inc. and Sarah Toomey. | S‑1/A | 333-276046 | 10.8 | 1/29/2024 | |
10.9† | Offer Letter, dated September 12, 2023, by and between Fractyl Health, Inc. and Timothy Kieffer, Ph.D. | S‑1/A | 333-276046 | 10.9 | 1/29/2024 | |
10.10† | First Amendment to Offer Letter, dated September 12, 2024, by and between Fractyl Health, Inc. and Timothy Kieffer, Ph.D. | S‑1/A | 333-276046 | 10.10 | 1/29/2024 | |
10.11† | Severance Agreement and Change in Control Agreement, dated September 12, 2023, by and between Fractyl Health, Inc. and Timothy Kieffer, Ph.D. | S‑1/A | 333-276046 | 10.11 | 1/29/2024 | |
10.12 † | First Amendment to Severance Agreement and Change in Control Agreement, by and between the Registrant and Timothy Kieffer, Ph.D. (to be in effect upon the effectiveness of this registration statement). | S-1/A | 333-276046 | 10.12 | 1/29/2024 | |
10.13 | Lease Agreement, dated August 10, 2022, by and between Fractyl Health, Inc. (f/k/a Fractyl Laboratories, Inc.) and BP 17 Hartwell LLC. | S-1 | 333-276046 | 10.11 | 12/14/2024 | |
10.14† | Fractyl Health, Inc. 2024 Incentive Award Plan and forms of award agreements thereunder. | * | ||||
10.15† | Fractyl Health, Inc. 2024 Employee Stock Purchase Plan. | S-1/A | 333-276046 | 10.16 | 1/29/2024 | |
10.16† | Fractyl Health, Inc. Non-Employee Director Compensation Program. | S-1/A | 333-276046 | 10.17 | 1/29/2024 | |
10.17† | Form of Indemnification Agreement by and among Fractyl Health, Inc. and its directors and officers. | S-1/A | 333-276046 | 10.18 | 12/14/2023 | |
21.1 | List of Subsidiaries | S‑1 | 333-276046 | 21.1 | 12/14/2023 | |
23.1 | Consent of Independent Registered Public Accounting Firm | * | ||||
31.1 | Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer | * | ||||
31.2 | Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer | * | ||||
32.1 | Section 1350 Certification of Chief Executive Officer | ** | ||||
32.2 | Section 1350 Certification of Chief Financial Officer | ** |
S-1/A
GUTS
Fractyl Health Inc.
29 Jan 24
IPO registration (amended)
6:09am
The following table summarizes the number of shares of common stock underlying outstanding equity incentive plan awards for each named executive officer as of December 31, 2023.
Option Awards | ||||||||||||||||||||||||||||
Name | Vesting Start Date | Underlying Un-exercised Options (#) Exercisable | Underlying Un-exercised Options (#) Un-exercisable | Option Exercise Price ($) | Option Expiration Date | Number of Shares or Units of Stock that have not Vested (#) | Market Value of Shares of Units of Stock that have not Vested ($)(1) | |||||||||||||||||||||
Harith Rajagopalan, M.D., Ph.D.(2) . | 8/19/2014 | 190,968 | 0 | 1.70 | 11/10/2024 | — | — | |||||||||||||||||||||
3/01/2015 | 123,484 | 0 | 1.70 | 2/09/2025 | — | — | ||||||||||||||||||||||
12/17/2015 | 345,078 | — | $ | 2.67 | 12/16/2025 | — | — | |||||||||||||||||||||
6/27/2016 | 179,868 | 0 | 2.67 | 6/26/2026 | — | — | ||||||||||||||||||||||
3/14/2018 | 422,473 | 0 | 3.35 | 3/13/2028 | — | — | ||||||||||||||||||||||
3/26/2020 | 445,333 | 29,688 | 3.89 | 3/25/2030 | — | — | ||||||||||||||||||||||
6/24/2021 | 164,335 | 98,602 | 6.98 | 6/23/2031 | — | — | ||||||||||||||||||||||
9/07/2022 | 5,096 | 11,213 | 8.59 | 9/06/2032 | — | — | ||||||||||||||||||||||
3/16/2023 | 6,116 | 26,502 | 8.18 | 3/15/2033 | — | — | ||||||||||||||||||||||
11/10/2023 | 0 | 17,031 | (3) | 11.21 | 11/09/2033 | — | — | |||||||||||||||||||||
$ | 3,253,86 | |||||||||||||||||||||||||||
11/10/2023 | — | — | — | 11/09/2030 | 216,924 | (7) | 0 | |||||||||||||||||||||
Timothy Kieffer, Ph.D. | 10/14/2022 | 5,436 | (4) | 3,883 | 8.59 | 12/06/2032 | — | — | ||||||||||||||||||||
9/12/2023 | 0 | 498,005 | (5) | 11.21 | 9/12/2033 | — | — | |||||||||||||||||||||
Jay D. Caplan(6) | 8/19/2014 | 95,484 | 0 | 0.82 | 11/10/2024 | — | — | |||||||||||||||||||||
3/01/2015 | 61,742 | 0 | 1.70 | 2/09/2025 | — | — | ||||||||||||||||||||||
12/17/2015 | 145,875 | — | $ | 2.67 | 12/16/2025 | — | — | |||||||||||||||||||||
6/27/2016 | 23,298 | 0 | 2.67 | 6/26/2026 | — | — | ||||||||||||||||||||||
3/14/2018 | 94,879 | 0 | 3.35 | 3/13/2028 | — | — | ||||||||||||||||||||||
3/26/2020 | 12,022 | 802 | 3.89 | 3/25/2030 | — | — | ||||||||||||||||||||||
6/24/2021 | 24,358 | 14,616 | 6.98 | 6/23/2031 | — | — | ||||||||||||||||||||||
9/07/2022 | 3,639 | 8,010 | 8.59 | 9/06/2032 | — | — | ||||||||||||||||||||||
3/16/2023 | 4,805 | 20,823 | 8.18 | 3/15/2033 | — | — | ||||||||||||||||||||||
11/10/2023 | 0 | 14,701 | (3) | 11.21 | 11/09/2033 | — | — | |||||||||||||||||||||
11/10/2023 | — | — | — | 11/09/2030 | 187,257 | (7) | $ | 2,808,855 |
S-1/A
p6jq px8o
29 Jan 24
IPO registration (amended)
6:09am
S-1/A
bp4lhitg4 2mr
29 Jan 24
IPO registration (amended)
6:09am
- Prev
- 1
- Next